CB Bureau

Ranbaxy introduces Rs 130 anti-malaria drug as its CSR

Synriam is India’s first indigenously developed drug for malaria treatment and a tablet a day for three days costs only Rs 130. Launched on World Malaria Day as part of Ranbaxy’s corporate social responsibility (CSR), Synriam is expected to become a part of India’s national malaria eradication programme. The drug has been developed by Ranbaxy…

Read More

Human Rights: Clean investigation sought in Eelam War; WB unit not educating; AP forum against mining; Officers trained in Karnataka

India has asked Sri Lanka to develop ‘independent, credible as well as transparent mechanism to investigate allegations of human rights violations that were reported during the end of Eelam War IV. Colombo has also been asked to give a deadline for the presentation of final reports of investigation . Commenting on the ‘Sri Lankan Lessons…

Read More